susan_lowther

IXICO hires chief financial officer

pharmafile | September 22, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

UK-based medical tech business IXICO has appointed Susan Lowther to its board as a chief financial officer. 

Lowther was previously group chief financial officer and a director of Novacyt, a European company listed on the French Alternext exchange that specialises in cancer and infectious disease diagnostic products and services.
 

Prior to this Lowther was chief financial officer and a director of Lab21 Group, which was acquired by Novacyt in June this year. She was previously chief executive at BioWisdom and has held finance roles in life science companies comprising: RiboTargets, Lonza Biologics, Celltech Group and Monsanto.
 

Advertisement

Commenting on the appointment Derek Hill, IXICO’s chief executive says: “We are delighted that Susan is joining the IXICO team. She brings a depth of financial and business experience that will help us continue to grow the business internationally.”

Related Content

No items found
The Gateway to Local Adoption Series

Latest content